1. Home
  2. VTYX vs HAIN Comparison

VTYX vs HAIN Comparison

Compare VTYX & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • HAIN
  • Stock Information
  • Founded
  • VTYX 2018
  • HAIN 1993
  • Country
  • VTYX United States
  • HAIN United States
  • Employees
  • VTYX N/A
  • HAIN N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • HAIN Packaged Foods
  • Sector
  • VTYX Health Care
  • HAIN Consumer Staples
  • Exchange
  • VTYX Nasdaq
  • HAIN Nasdaq
  • Market Cap
  • VTYX 154.9M
  • HAIN 121.9M
  • IPO Year
  • VTYX 2021
  • HAIN 1993
  • Fundamental
  • Price
  • VTYX $8.86
  • HAIN $1.25
  • Analyst Decision
  • VTYX Buy
  • HAIN Hold
  • Analyst Count
  • VTYX 3
  • HAIN 10
  • Target Price
  • VTYX $12.50
  • HAIN $3.48
  • AVG Volume (30 Days)
  • VTYX 9.5M
  • HAIN 1.6M
  • Earning Date
  • VTYX 11-06-2025
  • HAIN 11-07-2025
  • Dividend Yield
  • VTYX N/A
  • HAIN N/A
  • EPS Growth
  • VTYX N/A
  • HAIN N/A
  • EPS
  • VTYX N/A
  • HAIN N/A
  • Revenue
  • VTYX N/A
  • HAIN $1,559,780,000.00
  • Revenue This Year
  • VTYX N/A
  • HAIN N/A
  • Revenue Next Year
  • VTYX N/A
  • HAIN $0.91
  • P/E Ratio
  • VTYX N/A
  • HAIN N/A
  • Revenue Growth
  • VTYX N/A
  • HAIN N/A
  • 52 Week Low
  • VTYX $0.78
  • HAIN $1.27
  • 52 Week High
  • VTYX $8.52
  • HAIN $9.43
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 83.25
  • HAIN 33.79
  • Support Level
  • VTYX $5.75
  • HAIN $1.30
  • Resistance Level
  • VTYX $7.50
  • HAIN $1.52
  • Average True Range (ATR)
  • VTYX 0.66
  • HAIN 0.08
  • MACD
  • VTYX 0.44
  • HAIN -0.00
  • Stochastic Oscillator
  • VTYX 98.23
  • HAIN 3.70

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

Share on Social Networks: